【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 16
2 Introduction 17
2.1 Prosthetic Heart Valves Overview 17
3 Products under Development 18
3.1 Prosthetic Heart Valves – Pipeline Products by Stage of Development 18
3.2 Prosthetic Heart Valves – Pipeline Products by Segment 19
3.3 Prosthetic Heart Valves – Pipeline Products by Territory 20
3.4 Prosthetic Heart Valves – Pipeline Products by Regulatory Path 21
3.5 Prosthetic Heart Valves – Pipeline Products by Estimated Approval Date 22
3.6 Prosthetic Heart Valves – Ongoing Clinical Trials 23
4 Prosthetic Heart Valves – Pipeline Products under Development by Companies 24
4.1 Prosthetic Heart Valves Companies – Pipeline Products by Stage of Development 24
4.2 Prosthetic Heart Valves – Pipeline Products by Stage of Development 27
5 Prosthetic Heart Valves Companies and Product Overview 31
5.1 Aegis Surgical Limited Company Overview 31
5.1.1 Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview 31
5.2 AorTech International plc Company Overview 32
5.2.1 AorTech International plc Pipeline Products & Ongoing Clinical Trials Overview 32
5.3 Apica Cardiovascular Limited Company Overview 34
5.3.1 Apica Cardiovascular Limited Pipeline Products & Ongoing Clinical Trials Overview 34
5.4 Boston Children’s Hospital Company Overview 35
5.4.1 Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 35
5.5 Boston Scientific Corporation Company Overview 37
5.5.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 37
5.6 Braile Biomedica Ltda. Company Overview 46
5.6.1 Braile Biomedica Ltda. Pipeline Products & Ongoing Clinical Trials Overview 46
5.7 Caisson Interventional, LLC Company Overview 48
5.7.1 Caisson Interventional, LLC Pipeline Products & Ongoing Clinical Trials Overview 48
5.8 Cardiac Dimensions, Inc. Company Overview 49
5.8.1 Cardiac Dimensions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
5.9 CardiAQ Valve Technologies, Inc. Company Overview 53
5.9.1 CardiAQ Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
5.10 Cardio3 BioSciences SA Company Overview 59
5.10.1 Cardio3 BioSciences SA Pipeline Products & Ongoing Clinical Trials Overview 59
5.11 Cephea Valve Technologies, Inc. Company Overview 60
5.11.1 Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
5.12 Clemson University Company Overview 61
5.12.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview 61
5.13 Colibri Heart Valve, LLC Company Overview 62
5.13.1 Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview 62
5.14 CorMatrix Cardiovascular, Inc. Company Overview 70
5.14.1 CorMatrix Cardiovascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
5.15 CryoLife, Inc. Company Overview 75
5.15.1 CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
5.16 Cytograft Tissue Engineering, Inc. Company Overview 77
5.16.1 Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
5.17 Direct Flow Medical, Inc. Company Overview 78
5.17.1 Direct Flow Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
5.18 Dura Biotech Company Overview 83
5.18.1 Dura Biotech Pipeline Products & Ongoing Clinical Trials Overview 83
5.19 Edwards Lifesciences Corporation Company Overview 85
5.19.1 Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 85
5.20 Emory University Company Overview 106
5.20.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 106
5.21 HighLife SAS Company Overview 108
5.21.1 HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview 108
5.22 HLT, Inc. Company Overview 109
5.22.1 HLT, Inc. Pipeline Products & Ongoing Clinical Trials Overview 109
5.23 Innovia LLC Company Overview 112
5.23.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 112
5.24 JenaValve Technology GmbH Company Overview 115
5.24.1 JenaValve Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview 115
5.25 Leman Cardiovascular Company Overview 120
5.25.1 Leman Cardiovascular Pipeline Products & Ongoing Clinical Trials Overview 120
5.26 Mayo Clinic Company Overview 121
5.26.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 121
5.27 Medi-Line S.A. Company Overview 122
5.27.1 Medi-Line S.A. Pipeline Products & Ongoing Clinical Trials Overview 122
5.28 Medtronic plc Company Overview 123
5.28.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 123
5.29 Meril Life Sciences Pvt. Ltd. Company Overview 135
5.29.1 Meril Life Sciences Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 135
5.30 Micro Interventional Devices, Inc. Company Overview 136
5.30.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 136
5.31 MicroPort Scientific Corporation Company Overview 138
5.31.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 138
5.32 Mitralix Ltd. Company Overview 142
5.32.1 Mitralix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 142
5.33 MitrAssist Ltd. Company Overview 143
5.33.1 MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview 143
5.34 Mitricares Company Overview 144
5.34.1 Mitricares Pipeline Products & Ongoing Clinical Trials Overview 144
5.35 NaviGate Cardiac Structures, Inc. Company Overview 145
5.35.1 NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview 145
5.36 Neovasc Inc. Company Overview 146
5.36.1 Neovasc Inc. Pipeline Products & Ongoing Clinical Trials Overview 146
5.37 Peca Labs, Inc. Company Overview 150
5.37.1 Peca Labs, Inc. Pipeline Products & Ongoing Clinical Trials Overview 150
5.38 PolyNova Cardiovascular LLC Company Overview 151
5.38.1 PolyNova Cardiovascular LLC Pipeline Products & Ongoing Clinical Trials Overview 151
5.39 RegenaGraft Company Overview 152
5.39.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview 152
5.40 Revivicor, Inc. Company Overview 153
5.40.1 Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 153
5.41 SAS Cormove Company Overview 154
5.41.1 SAS Cormove Pipeline Products & Ongoing Clinical Trials Overview 154
5.42 Scientific and Production Center Amphion, LLC Company Overview 155
5.42.1 Scientific and Production Center Amphion, LLC Pipeline Products & Ongoing Clinical Trials Overview 155
5.43 Sorin S.p.A. Company Overview 156
5.43.1 Sorin S.p.A. Pipeline Products & Ongoing Clinical Trials Overview 156
5.44 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 160
5.44.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 160
5.45 St. Jude Medical, Inc. Company Overview 162
5.45.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 162
5.46 Stellenbosch University Company Overview 175
5.46.1 Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview 175
5.47 Strait Access Technologies (Pty) Ltd Company Overview 176
5.47.1 Strait Access Technologies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview 176
5.48 Symetis AG Company Overview 178
5.48.1 Symetis AG Pipeline Products & Ongoing Clinical Trials Overview 178
5.49 Tendyne Medical, Inc. Company Overview 184
5.49.1 Tendyne Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 184
5.50 The Tel Aviv Sourasky Medical Center Company Overview 187
5.50.1 The Tel Aviv Sourasky Medical Center Pipeline Products & Ongoing Clinical Trials Overview 187
5.51 Thubrikar Aortic Valve, Inc. Company Overview 188
5.51.1 Thubrikar Aortic Valve, Inc. Pipeline Products & Ongoing Clinical Trials Overview 188
5.52 Tissue Regenix Ltd Company Overview 190
5.52.1 Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview 190
5.53 Transcatheter Technologies GmbH Company Overview 193
5.53.1 Transcatheter Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 193
5.54 Twelve, Inc Company Overview 196
5.54.1 Twelve, Inc Pipeline Products & Ongoing Clinical Trials Overview 196
5.55 UMC Utrecht Holding BV Company Overview 197
5.55.1 UMC Utrecht Holding BV Pipeline Products & Ongoing Clinical Trials Overview 197
5.56 University College London Company Overview 198
5.56.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 198
5.57 University of California, Irvine Company Overview 199
5.57.1 University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview 199
5.58 University of Pennsylvania Company Overview 202
5.58.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 202
5.59 Valtech Cardio Ltd. Company Overview 204
5.59.1 Valtech Cardio Ltd. Pipeline Products & Ongoing Clinical Trials Overview 204
5.60 ValveXchange, Inc. Company Overview 205
5.60.1 ValveXchange, Inc. Pipeline Products & Ongoing Clinical Trials Overview 205
5.61 VueKlar Cardiovascular Ltd. Company Overview 208
5.61.1 VueKlar Cardiovascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 208
5.62 Xeltis AG Company Overview 210
5.62.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 210
6 Prosthetic Heart Valves- Recent Developments 211
7 Appendix 306
7.1 Methodology 306
7.2 About GlobalData 308
7.3 Contact Us 309
7.4 Disclaimer 309
【レポート販売概要】
■ タイトル：人工心臓弁の世界市場：パイプラインレビュー2015■ 英文：Prosthetic Heart Valves - Pipeline Review, 2015
■ 発行日：2015年4月28日
■ 調査会社：GlobalData
■ 商品コード：GDME0006EPD
■ 調査対象地域：グローバル
- 世界の高度CO2センサー市場動向（2012-2016）TechNavio's analysts forecast the Global Advanced CO2 Sensors market to grow at a CAGR of 32.5 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for location-specific CO2 sensors. The Global Advanced CO2 Sensors market has also been witnessing the increasing institutional usage of CO2 sensors. However, the high cost of advanced CO …
- 西ヨーロッパのデータセンターコロケーション市場2016-2020About Data Center Colocation Data center colocation is a facility for renting computing servers and storage to other organizations. It provides options such as power, bandwidth, and physical security to servers and storage. Colocation is useful for customers across industry verticals. It helps reduce spending on IT infrastructure and improve security and ownership control of the data. Technavio’s …
- マシンビジョンの世界市場：PC基盤マシンビジョン、スマートカメラ基盤マシンビジョンForecast the machine vision market to grow from USD 8.08 Billion in 2015 to USD 12.50 Billion by 2020, at a CAGR of 9.1% between 2015 and 2020. Increasing need for quality inspection and automation, growing demand for vision-guided robotics system, rise in wages of labor in china which increases the investment opportunities in vision-guided robots, growing number of regulatory mandates in manufact …
- 液化石油ガス（LPG）の世界市場2019-2023About this market Technological advances to drive growth in the market. With the rising popularity of LPG as an efficient fuel, there have been several technological developments being carried out globally to make the use of LPG convenient and cost-effective. Technavio’s analysts have predicted that the liquefied petroleum gas market will register a CAGR of almost 3% by 2023. Market Overview Incre …
- Iberdrola, S.A.：石油・ガスバリューチェーン分析レポート2013Iberdrola, S.A. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Iberdrola, S.A." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Iberdrola, S.A.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the compan …
- 世界における凝固検査機器市場及び主要サプライヤー動向This 71-page report reviews current instrumentation technologies, and compares features of leading automated and semiautomated analyzers.The report also presents strategic assessments of current and emerging suppliers of coagulation products, including marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.Contains 71 pages
- 性器ヘルペス(Genital Herpes)：世界の治験レビュー（2015年上半期版）Genital Herpes Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Genital Herpes Global Clinical Trials Review, H1, 2015" provides an overview of Genital Herpes clinical trials scenario. This report provides top line data relating to the clinical trials on Genital Herpes. Report includes an overview of trial numbers and their average enrollment in top countries co …
- グローバルにおける高コレステロール血症（高脂血症）治療市場（2014-2018）About Hypercholesterolemia Hypercholesterolemia is defined as a condition characterized by abnormally high levels of total cholesterol and LDL cholesterol in the blood. High cholesterol levels, in turn, can lead to cardiovascular diseases such as atherosclerosis and stroke. The normal physiological range of total blood cholesterol is 140-200 mg/dL. However, blood cholesterol consists of various in …
- 自動外観検査（AOI）システムの世界市場：2D AOIシステム、3D AOIシステムThe automated optical inspection (AOI) system market is expected to reach USD 1,008.8 Million by 2022, at a CAGR of 17.1% between 2016 and 2022. The growth of this market is propelled by the miniaturization of PCBs, increasing demand for consumer electronics, and proliferation of electronics in the automotive sector. The 2D system is expected to hold a large share of the overall Automated Optical …
- メキシコの手術室用装置市場見通し（～2021）Mexico Operating Room Equipment Market Outlook to 2021 Summary GlobalData’s new report, "Mexico Operating Room Equipment Market Outlook to 2021", provides key market data on the Mexico Operating Room Equipment market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Operating Room Tables, Operating Room Lights …
- 食品産業用ロボットの世界市場予測（～2022年）“The global food robotics market is projected to grow at a CAGR of 12.80%.”The global food robotics market is estimated at USD 1.37 billion in 2017 and is projected to reach USD 2.50 billion by 2022, at a CAGR of 12.80% during the forecast period. The primary factors that drive the market are increasing food safety regulations, higher demand for packaged foods, and the increasing need to improve p …
- 脂肪種子および雑穀種子の世界市場About Oilseeds and Grain Seeds Oilseeds are seeds that contain a significant quantity of oil, enough to warrant its extraction. They include seeds such as soybeans, canola, pennycress, and sunflower. Grain seeds include seeds cultivated for their yield of grains, such as wheat, rice, oats, barley, corn, and sorghum. Modern seeds are biotechnologically enhanced. The market for oilseeds and grain se …
- Uveitis：市場分析及び予測（～2017）OpportunityAnalyzer: Uveitis - Opportunity Analysis and Forecasts to 2017 Summary Uveitis is an expanding market currently dominated by corticosteroid treatment options as well as off-label immunosuppressive and biologic drugs. Since the conventional corticosteroid treatment is only effective in 50-60% of patients a significant number of patients can be targeted with the new treatment options. Whi …
- 慢性肝疾患(Chronic Liver Disease)：世界の治験レビュー（2015年上半期版）Chronic Liver Disease Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Chronic Liver Disease Global Clinical Trials Review, H1, 2015" provides an overview of Chronic Liver Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Liver Disease. Report includes an overview of trial numbers and their average en …
- スマートホスピタリティの世界市場予測（～2021）：ソフトウェア別（ホテル運営管理システム、ホテルビルオートメーションシステム）、サービス別、ホテル種類別、導入モデル別、地域別The smart hospitality market size is expected to grow from USD 5.74 Billion in 2016 to USD 18.11 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 25.8%. The major drivers for upsurge in demand for smart hospitality software and services include growing demand for real-time optimized guest experience management, luring revenue generation & low operational costs, and increasing adoption o …
